Market Tracker

01/20 5:06pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

11.33
Delayed Data
As of 4:00pm ET
 +0.54 / +5.00%
Today’s Change
9.23
Today|||52-Week Range
29.12
+10.21%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close10.79
Today’s open10.89
Day’s range10.83 - 11.42
Volume239,194
Average volume (3 months)303,702
Market cap$314.4M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-119.15%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book1.59

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...-0.17-1.47%
RARXRa Pharmaceuticals I...+0.72+5.12%
SRNESorrento Therapeutic...+0.10+1.89%
MNKDMannKind Corp-0.01-1.83%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts